TY - JOUR AU - Siegel, R. L. AU - Miller, K. D. AU - Jemal, A. PY - 2016 DA - 2016// TI - Cancer statistics, 2016 JO - CA Cancer J Clin VL - 66 UR - https://doi.org/10.3322/caac.21332 DO - 10.3322/caac.21332 ID - Siegel2016 ER - TY - STD TI - SEER Cancer Statistics Review, 1973-1999. National Cancer Institute, Bethesda, MD. 2002. https://seer.cancer.gov/archive/csr/1973_1999/. Accessed 30 Aug 2012. UR - https://seer.cancer.gov/archive/csr/1973_1999/ ID - ref2 ER - TY - JOUR AU - Friedel, G. AU - Hruska, D. AU - Budach, W. AU - Wolf, M. AU - Kyriss, T. AU - Hurtgen, M. PY - 2000 DA - 2000// TI - Neoadjuvant chemoradiotherapy of stage III non-small-cell lung cancer JO - Lung Cancer VL - 30 UR - https://doi.org/10.1016/S0169-5002(00)00151-3 DO - 10.1016/S0169-5002(00)00151-3 ID - Friedel2000 ER - TY - JOUR AU - Bonomi, P. D. AU - Finkelstein, D. M. AU - Ruckdeschel, J. C. AU - Blum, R. H. AU - Green, M. D. AU - Mason, B. PY - 1989 DA - 1989// TI - Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the eastern cooperative oncology group JO - J Clin Oncol VL - 7 UR - https://doi.org/10.1200/JCO.1989.7.11.1602 DO - 10.1200/JCO.1989.7.11.1602 ID - Bonomi1989 ER - TY - JOUR AU - Fossella, F. AU - Pereira, J. R. AU - Pawel, J. AU - Pluzanska, A. AU - Gorbounova, V. AU - Kaukel, E. PY - 2003 DA - 2003// TI - Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: the TAX 326 study group JO - J Clin Oncol VL - 21 UR - https://doi.org/10.1200/JCO.2003.12.046 DO - 10.1200/JCO.2003.12.046 ID - Fossella2003 ER - TY - JOUR AU - Kelly, K. AU - Crowley, J. AU - Bunn, P. A. AU - Presant, C. A. AU - Grevstad, P. K. AU - Moinpour, C. M. PY - 2001 DA - 2001// TI - Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non--small-cell lung cancer: a southwest oncology group trial JO - J Clin Oncol VL - 19 UR - https://doi.org/10.1200/JCO.2001.19.13.3210 DO - 10.1200/JCO.2001.19.13.3210 ID - Kelly2001 ER - TY - JOUR AU - Schiller, J. H. AU - Harrington, D. AU - Belani, C. P. AU - Langer, C. AU - Sandler, A. AU - Krook, J. PY - 2002 DA - 2002// TI - Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer JO - N Engl J Med VL - 346 UR - https://doi.org/10.1056/NEJMoa011954 DO - 10.1056/NEJMoa011954 ID - Schiller2002 ER - TY - JOUR AU - Sandler, A. AU - Gray, R. AU - Perry, M. C. AU - Brahmer, J. AU - Schiller, J. H. AU - Dowlati, A. PY - 2006 DA - 2006// TI - Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer JO - N Engl J Med VL - 355 UR - https://doi.org/10.1056/NEJMoa061884 DO - 10.1056/NEJMoa061884 ID - Sandler2006 ER - TY - JOUR AU - Patel, J. D. AU - Socinski, M. A. AU - Garon, E. B. AU - Reynolds, C. H. AU - Spigel, D. R. AU - Olsen, M. R. PY - 2013 DA - 2013// TI - PointBreak: a randomized phase III study of pemetrexed plus carboplatin and bevacizumab followed by maintenance pemetrexed and bevacizumab versus paclitaxel plus carboplatin and bevacizumab followed by maintenance bevacizumab in patients with stage IIIB or IV nonsquamous non-small-cell lung cancer JO - J Clin Oncol VL - 31 UR - https://doi.org/10.1200/JCO.2012.47.9626 DO - 10.1200/JCO.2012.47.9626 ID - Patel2013 ER - TY - JOUR AU - Barlesi, F. AU - Scherpereel, A. AU - Gorbunova, V. AU - Gervais, R. AU - Vikstrom, A. AU - Chouaid, C. PY - 2014 DA - 2014// TI - Maintenance bevacizumab-pemetrexed after first-line cisplatin-pemetrexed-bevacizumab for advanced nonsquamous nonsmall-cell lung cancer: updated survival analysis of the AVAPERL (MO22089) randomized phase III trial JO - Ann Oncol VL - 25 UR - https://doi.org/10.1093/annonc/mdu098 DO - 10.1093/annonc/mdu098 ID - Barlesi2014 ER - TY - JOUR AU - Spigel, D. R. AU - Patel, J. D. AU - Reynolds, C. H. AU - Garon, E. B. AU - Hermann, R. C. AU - Govindan, R. PY - 2015 DA - 2015// TI - Quality of life analyses from the randomized, open-label, phase III PointBreak study of pemetrexed-carboplatin-bevacizumab followed by maintenance pemetrexed-bevacizumab versus paclitaxel-carboplatin-bevacizumab followed by maintenance bevacizumab in patients with stage IIIB or IV nonsquamous non-small-cell lung cancer JO - J Thorac Oncol VL - 10 UR - https://doi.org/10.1097/JTO.0000000000000277 DO - 10.1097/JTO.0000000000000277 ID - Spigel2015 ER - TY - JOUR AU - Rittmeyer, A. AU - Gorbunova, V. AU - Vikstrom, A. AU - Scherpereel, A. AU - Kim, J. H. AU - Ahn, M. J. PY - 2013 DA - 2013// TI - Health-related quality of life in patients with advanced nonsquamous non-small-cell lung cancer receiving bevacizumab or bevacizumab-plus-pemetrexed maintenance therapy in AVAPERL (MO22089) JO - J Thorac Oncol VL - 8 UR - https://doi.org/10.1097/JTO.0b013e3182a46bcf DO - 10.1097/JTO.0b013e3182a46bcf ID - Rittmeyer2013 ER - TY - JOUR AU - Lauro, S. AU - Onesti, C. E. AU - Righini, R. AU - Marchetti, P. PY - 2014 DA - 2014// TI - The use of bevacizumab in non-small cell lung cancer: an update JO - Anticancer Res VL - 34 ID - Lauro2014 ER - TY - JOUR AU - Vokes, E. E. AU - Salgia, R. AU - Karrison, T. G. PY - 2013 DA - 2013// TI - Evidence-based role of bevacizumab in non-small cell lung cancer JO - Ann Oncol VL - 24 UR - https://doi.org/10.1093/annonc/mds608 DO - 10.1093/annonc/mds608 ID - Vokes2013 ER - TY - JOUR AU - Iyer, S. AU - Roughley, A. AU - Rider, A. AU - Taylor-Stokes, G. PY - 2014 DA - 2014// TI - The symptom burden of non-small cell lung cancer in the USA: a real-world cross-sectional study JO - Support Care Cancer VL - 22 UR - https://doi.org/10.1007/s00520-013-1959-4 DO - 10.1007/s00520-013-1959-4 ID - Iyer2014 ER - TY - JOUR AU - Chouaid, C. AU - Agulnik, J. AU - Goker, E. AU - Herder, G. J. AU - Lester, J. F. AU - Vansteenkiste, J. PY - 2013 DA - 2013// TI - Health-related quality of life and utility in patients with advanced non-small-cell lung cancer: a prospective cross-sectional patient survey in a real-world setting JO - J Thorac Oncol VL - 8 UR - https://doi.org/10.1097/JTO.0b013e318299243b DO - 10.1097/JTO.0b013e318299243b ID - Chouaid2013 ER - TY - JOUR AU - Walker, M. S. AU - Hasan, M. AU - Yim, Y. M. AU - Yu, E. AU - Stepanski, E. J. AU - Schwartzberg, L. S. PY - 2011 DA - 2011// TI - Retrospective study of the effect of disease progression on patient reported outcomes in HER-2 negative metastatic breast cancer patients JO - Health Qual Life Outcomes VL - 9 UR - https://doi.org/10.1186/1477-7525-9-46 DO - 10.1186/1477-7525-9-46 ID - Walker2011 ER - TY - JOUR AU - Aaronson, N. K. AU - Ahmedzai, S. AU - Bergman, B. AU - Bullinger, M. AU - Cull, A. AU - Duez, N. J. PY - 1993 DA - 1993// TI - The European Organization for Research and Treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology JO - J Natl Cancer Inst VL - 85 UR - https://doi.org/10.1093/jnci/85.5.365 DO - 10.1093/jnci/85.5.365 ID - Aaronson1993 ER - TY - JOUR AU - Bergman, B. AU - Aaronson, N. K. AU - Ahmedzai, S. AU - Kaasa, S. AU - Sullivan, M. PY - 1994 DA - 1994// TI - The EORTC QLQ-LC13: a modular supplement to the EORTC Core quality of life questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC study group on quality of life JO - Eur J Cancer VL - 30A UR - https://doi.org/10.1016/0959-8049(94)90535-5 DO - 10.1016/0959-8049(94)90535-5 ID - Bergman1994 ER - TY - JOUR AU - Cleeland, C. S. AU - Mendoza, T. R. AU - Wang, X. S. AU - Chou, C. AU - Harle, M. T. AU - Morrissey, M. PY - 2000 DA - 2000// TI - Assessing symptom distress in cancer patients: the M.D. Anderson symptom inventory JO - Cancer VL - 89 UR - https://doi.org/3.0.CO;2-V DO - 3.0.CO;2-V ID - Cleeland2000 ER - TY - JOUR AU - Mendoza, T. R. AU - Wang, X. S. AU - Lu, C. AU - Palos, G. R. AU - Liao, Z. AU - Mobley, G. M. PY - 2011 DA - 2011// TI - Measuring the symptom burden of lung cancer: the validity and utility of the lung cancer module of the M. D. Anderson symptom inventory JO - Oncologist VL - 16 UR - https://doi.org/10.1634/theoncologist.2010-0193 DO - 10.1634/theoncologist.2010-0193 ID - Mendoza2011 ER - TY - BOOK AU - Haes, J. C. J. M. AU - Olschewski, M. AU - Fayers, P. M. AU - Visser, M. R. M. AU - Cull, A. AU - Hopwood, P. PY - 1996 DA - 1996// TI - Measuring the quality of life of cancer patients with the Rotterdam symptom checklist: a manual PB - Northern Centre for Healthcare Research (NCH) CY - Groningen, The Netherlands ID - Haes1996 ER - TY - JOUR AU - Cnaan, A. AU - Laird, N. M. AU - Slasor, P. PY - 1997 DA - 1997// TI - Using the general linear mixed model to analyse unbalanced repeated measures and longitudinal data JO - Stat Med VL - 16 UR - https://doi.org/3.0.CO;2-E DO - 3.0.CO;2-E ID - Cnaan1997 ER - TY - JOUR AU - Littell, R. C. AU - Pendergast, J. AU - Natarajan, R. PY - 2000 DA - 2000// TI - Modelling covariance structure in the analysis of repeated measures data JO - Stat Med VL - 19 UR - https://doi.org/3.0.CO;2-Q DO - 3.0.CO;2-Q ID - Littell2000 ER - TY - JOUR AU - Sloan, J. A. AU - Frost, M. H. AU - Berzon, R. AU - Dueck, A. AU - Guyatt, G. AU - Moinpour, C. PY - 2006 DA - 2006// TI - The clinical significance of quality of life assessments in oncology: a summary for clinicians JO - Support Care Cancer VL - 14 UR - https://doi.org/10.1007/s00520-006-0085-y DO - 10.1007/s00520-006-0085-y ID - Sloan2006 ER -